Ali Zare Dehnavi on AI’s Impact on Stroke
Ali Zare Dehnavi, Clinical Innovation Adviosr at March Health, shared on LinkedIn:
”One area of AI deployment I’m particularly interested in is acute neurovascular and critical care, where time to diagnosis and team activation directly affects outcomes.
Recent work from Aidoc and Viz.ai shows what meaningful clinical AI actually looks like in practice.
Aidoc’s FDA-cleared stroke suite enables parallel triage of ischemic stroke (LVO on CTA) and intracranial hemorrhage (NCCT), with published data showing ~35–40% reductions in turnaround time for critical findings and faster escalation to treatment teams.
Viz.ai, deployed within real stroke networks, has demonstrated door-in–door-out reductions from ~200 minutes to ~105 minutes in inter-facility stroke transfers, driven by rapid LVO detection, immediate image access, and real-time team communication.
What’s notable here isn’t the algorithms in isolation, but the compression of imaging-to-decision time and earlier coordination across teams.
In stroke care, those gains translate into earlier anticoagulation, faster thrombectomy pathways, and improved functional outcomes reported in multiple centers.”
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’